These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6869694)

  • 21. [Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].
    Wolters A; Benecke R
    MMW Fortschr Med; 2007 May; 149 Suppl 2():94-6. PubMed ID: 17724978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of apomorphine in clinical practice.
    MacMahon DG
    Adv Neurol; 1999; 80():529-33. PubMed ID: 10410767
    [No Abstract]   [Full Text] [Related]  

  • 24. Bilateral tremor relations in Parkinson's disease: effects of mechanical coupling and medication.
    Morrison S; Kerr G; Silburn P
    Parkinsonism Relat Disord; 2008; 14(4):298-308. PubMed ID: 17977054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The possibilities of using himantane in the treatment of Parkinson's disease].
    Katunina EA; Petrukhova AV; Avakian GN; Val'dman EA; Nerobkova LN; Voronina TA; Saiadian KhS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):24-7. PubMed ID: 18577930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease.
    Clarke CE; Moore AP
    Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619
    [No Abstract]   [Full Text] [Related]  

  • 27. Medical treatment of essential tremor and Parkinson's disease.
    Uitti RJ
    Geriatrics; 1998 May; 53(5):46-8, 53-7. PubMed ID: 9597979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiparkinson medications improve agonist activation but not antagonist inhibition during sequential reaching movements.
    Kelly VE; Bastian AJ
    Mov Disord; 2005 Jun; 20(6):694-704. PubMed ID: 15719427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating QTc in patients with advanced Parkinson's disease: overcoming artifact.
    Bloomfield DM
    Clin Pharmacol Ther; 2009 Apr; 85(4):365-6. PubMed ID: 19295536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does thalamotomy alter the course of Parkinson's disease?
    Tasker RR; DeCarvalho GC; Li CS; Kestle JR
    Adv Neurol; 1996; 69():563-83. PubMed ID: 8615182
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effectiveness of modern antiparkinson agents].
    Kurako IuL; Volianskiĭ VE; Fadeev SM
    Vrach Delo; 1981 Feb; (2):7-11. PubMed ID: 7222616
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmaceutical care of Parkinson patients].
    Lennecke K
    Med Monatsschr Pharm; 2005 Jul; 28(7):228-36; quiz 237-8. PubMed ID: 16038120
    [No Abstract]   [Full Text] [Related]  

  • 34. Future delivery systems for apomorphine in patients with Parkinson's disease.
    van Laar T; Van der Geest R; Danhof M
    Adv Neurol; 1999; 80():535-44. PubMed ID: 10410768
    [No Abstract]   [Full Text] [Related]  

  • 35. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease].
    Kuiper MA; Zwaan WA; Wolters EC
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892
    [No Abstract]   [Full Text] [Related]  

  • 36. [Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure].
    Lökk J
    Lakartidningen; 2004 Jun; 101(23):2003-6. PubMed ID: 15232837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Motor symptoms in Parkinson disease].
    Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy of Parkinson disease].
    Schneider E
    Med Monatsschr Pharm; 2000 Apr; 23(4):116-24. PubMed ID: 10812899
    [No Abstract]   [Full Text] [Related]  

  • 39. Tremor in Parkinson's disease: 24-hr monitoring with calibrated accelerometry.
    Thielgen T; Foerster F; Fuchs G; Hornig A; Fahrenberg J
    Electromyogr Clin Neurophysiol; 2004; 44(3):137-46. PubMed ID: 15125053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.